Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …

Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …

Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …

Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …

Background A rapid increase in cases due to the SARS-CoV-2 Omicron (B.1.1.529) variant
in highly vaccinated populations has raised concerns about the effectiveness of current …

Background: When a clinical treatment fails or shows suboptimal results, the question of
when to switch to another treatment arises. Treatment switching strategies are often dynamic …

The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily
based on age; by 7th March 2021 approximately 93% of the English population aged 70…

Despite evidence suggesting that some migrants are at risk of under-immunization and have
experienced severe health inequities during the pandemic, data are limited on migrants’ …

Objective To determine characteristics associated with COVID-19 vaccine coverage among
individuals aged 50 years and above in England since the beginning of the programme. …

Of the 58,186 coronavirus deaths among adults in England during March–December 2020,
77% occurred in hospitals, 93% were in patients> 60 years, and 91% occurred within 28 …